Difference between revisions of "Stop-venlafaxine"

From Psychiatrienet
Jump to: navigation, search
(Created page with '{{Drugswitch | from = venlafaxine | stop = {{StopAlgemeen}} * 150 mg/day: :*'''Day 1:''' reduce dosage of venlafaxine to 75 mg/day. :* '''Day 15:''' reduce dosage of venlafaxine...')
 
Line 2: Line 2:
 
| from = venlafaxine
 
| from = venlafaxine
 
| stop = {{StopAlgemeen}}
 
| stop = {{StopAlgemeen}}
* 150 mg/day:
+
* 150 mg/day <ref>{{Pubmed|9396960|Fava M et al. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. Am J Psychiatry. 1997 Dec;154(12):1760-2}}</ref>:
 
:*'''Day 1:''' reduce dosage of venlafaxine to 75 mg/day.  
 
:*'''Day 1:''' reduce dosage of venlafaxine to 75 mg/day.  
 
:* '''Day 15:''' reduce dosage of venlafaxine to 37.5 mg/day.  
 
:* '''Day 15:''' reduce dosage of venlafaxine to 37.5 mg/day.  
 
:* '''Day 29:''' stop administration of venlafaxine.
 
:* '''Day 29:''' stop administration of venlafaxine.
 
}}
 
}}

Revision as of 14:38, 18 July 2011

Venlafaxine
Type Antidepressant
Group SNRI
links
Medscape Venlafaxine
PubChem 5656
PubMed Venlafaxine
Kompas (Dutch) Venlafaxine
Wikipedia Venlafaxine


Nietinrijdenbord.png Stop venlafaxine
  • In general after long-term maintenance treatment, the best is to reduce the dose by about 25% every 4-6 weeks. An apt pharmaceutical dose (tablet, capsule, mixture) is not always available. In these cases one should be creative with dosing.[1][2]
  • Another, more risky, possibility is being at a certain dose to use the following scheme:
  • 150 mg/day [3]:
  • Day 1: reduce dosage of venlafaxine to 75 mg/day.
  • Day 15: reduce dosage of venlafaxine to 37.5 mg/day.
  • Day 29: stop administration of venlafaxine.



  1. The UK Drug and Therapeutics Bulletin; 1999;37:49-52
  2. Editor: please note that not all dosages are available in pharmacy. So now and then you should be creative.
  3. Fava M et al. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. Am J Psychiatry. 1997 Dec;154(12):1760-2
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.